The above article was sent to subscribers in Pharmacy Daily's issue from 08 Sep 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Sep 11
AS PATIENTS struggle to pay for their medicine, the Pharmacy Guild of Australia has urged the Government to act to make medicines more affordable.
THE Therapeutic Goods Administration (TGA) has approved Wegovy 2.4mg (semaglutide) to be used as a complementary therapy for reducing major adverse cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction (heart attack), or non-fatal stroke.
AUSTRALIAN Prescriber is celebrating its 50 year anniversary this year, thanking its 100,000 plus healthcare subscribers for their continued support over the years.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.